High-throughput microarray technologies: from genomics to clinics.
about
Tissue MicroArray (TMA) analysis of normal and persistent Chlamydophila pneumoniae infectionNetwork analysis of differential expression for the identification of disease-causing genes.Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer.Application of new tissue microarrayer-ZM-1 without recipient paraffin block.In situ hybridization: an informative technique for pigment cell researchers.Molecular biomarkers in urothelial bladder cancer.Biomarkers in bladder cancer: present status and perspectives.Towards in vitro molecular diagnostics using nanostructures.A tissue fixative that protects macromolecules (DNA, RNA, and protein) and histomorphology in clinical samples.Molecular markers in bladder cancer: Novel research frontiers.Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age.Automatic Spot Identification for High Throughput Microarray Analysis.High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancerWarburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor.Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer.Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer.Profiling and classification tree applied to renal epithelial tumours
P2860
Q21261768-A4884F98-2AAF-421A-9B0F-CFBE39F32CD7Q33444792-00F122FA-FE88-4EEF-8CEF-830B32B9CAD3Q33650639-EC3682EC-EDC9-4E36-BD70-107B8459D3E3Q34425688-CE5AF916-CB12-48D0-A142-50AF27AA7B87Q35626419-190A3AE8-4507-4058-9F44-4603A878E847Q37123497-3BD47F1E-81AB-420E-A79A-9ACB9895421DQ37281006-08CA28B0-7C36-43E1-95F9-2C758D1CB41AQ37947136-3BAA8552-E89D-474B-A93E-4CD68F92C1B1Q38450460-1C617FEC-0AA7-428B-9776-57C956A8BD4BQ38520403-2358B004-DFD2-4E21-8497-11C078F584E2Q39702793-361FCC0C-6C1E-4A76-A89C-798B179EE5DDQ42252756-372AE0C0-FF78-4105-9DA3-FADD6C449AA4Q42414387-88080CB4-93BA-49D4-B578-CDB6E7443A5AQ44320068-E665E1D0-50DF-48CE-A9D2-C3A6EDF85733Q52623792-8EB06612-5E50-4B7F-B420-89A66DAFA561Q55371418-F166A65C-2664-407E-BADE-B5621C9C81C2Q57565184-C5F12650-9640-4738-BD8B-36C7906E3A38
P2860
High-throughput microarray technologies: from genomics to clinics.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
High-throughput microarray technologies: from genomics to clinics.
@ast
High-throughput microarray technologies: from genomics to clinics.
@en
type
label
High-throughput microarray technologies: from genomics to clinics.
@ast
High-throughput microarray technologies: from genomics to clinics.
@en
prefLabel
High-throughput microarray technologies: from genomics to clinics.
@ast
High-throughput microarray technologies: from genomics to clinics.
@en
P356
P1433
P1476
High-throughput microarray technologies: from genomics to clinics.
@en
P2093
Bubendorf L
P304
P356
10.1159/000049777
P407
P577
2001-08-01T00:00:00Z